Maravai LifeSciences Holdings, Inc. Deferred Tax Assets, Investments
Maravai LifeSciences Holdings, Inc. (MRVI) had Deferred Tax Assets, Investments of $558.38 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Investments $558.38M.
- 2024-12-31: Deferred Tax Assets, Investments $584.28M.
- 2023-12-31: Deferred Tax Assets, Investments $595.80M.
- 2022-12-31: Deferred Tax Assets, Investments $636.50M.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2025-12-31 | $558.38M 10-K · filed 2026-02-26 |
| 2024-12-31 | $584.28M 10-K · filed 2026-02-26 |
| 2023-12-31 | $595.80M 10-K · filed 2025-03-18 |
| 2022-12-31 | $636.50M 10-K · filed 2024-02-29 |
| 2021-12-31 | $675.86M 10-K · filed 2023-02-28 |
| 2020-12-31 | $360.86M 10-K · filed 2022-03-01 |